These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34661039)

  • 1. Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Tulberg A; McNamara M; Grogan TR; Abbott DH; Naik R; Lu G; Chazenbalk GD
    J Endocr Soc; 2021 Nov; 5(11):bvab158. PubMed ID: 34661039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Tulberg A; Leung KL; Fisch SC; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2021 Jul; 116(1):232-242. PubMed ID: 33341231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome.
    Dumesic DA; Turcu AF; Liu H; Grogan TR; Abbott DH; Lu G; Dharanipragada D; Chazenbalk GD
    J Endocr Soc; 2023 Jul; 7(8):bvad079. PubMed ID: 37404244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.
    Dumesic DA; Phan JD; Leung KL; Grogan TR; Ding X; Li X; Hoyos LR; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2171-2183. PubMed ID: 30649347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Winnett C; Lu G; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2023 Jan; 119(1):116-126. PubMed ID: 36400597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Akopians AL; Madrigal VK; Ramirez E; Margolis DJ; Sarma MK; Thomas AM; Grogan TR; Haykal R; Schooler TA; Okeya BL; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4178-4188. PubMed ID: 27571186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome.
    Fisch SC; Nikou AF; Wright EA; Phan JD; Leung KL; Grogan TR; Abbott DH; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Dec; 110(7):1367-1376. PubMed ID: 30503136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome.
    O'Reilly MW; Kempegowda P; Walsh M; Taylor AE; Manolopoulos KN; Allwood JW; Semple RK; Hebenstreit D; Dunn WB; Tomlinson JW; Arlt W
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3327-3339. PubMed ID: 28645211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome.
    O'Reilly M; Gathercole L; Capper F; Arlt W; Tomlinson J
    Lancet; 2015 Feb; 385 Suppl 1():S16. PubMed ID: 26312838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High salivary testosterone-to-androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome.
    Münzker J; Lindheim L; Adaway J; Trummer C; Lerchbaum E; Pieber TR; Keevil B; Obermayer-Pietsch B
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):567-575. PubMed ID: 28039871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.
    Tan BK; Chen J; Lehnert H; Kennedy R; Randeva HS
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2764-72. PubMed ID: 17456573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming.
    Leung KL; Sanchita S; Pham CT; Davis BA; Okhovat M; Ding X; Dumesic P; Grogan TR; Williams KJ; Morselli M; Ma F; Carbone L; Li X; Pellegrini M; Dumesic DA; Chazenbalk GD
    Clin Epigenetics; 2020 Nov; 12(1):181. PubMed ID: 33228780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
    Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Bartoszewicz Z; Kondracka A; Jaźwiec R; Samborowska E; Dadlez M; Wysłouch-Cieszyńska A; Bednarczuk T
    Ginekol Pol; 2017; 88(1):5-8. PubMed ID: 28157253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.
    Mannerås-Holm L; Leonhardt H; Kullberg J; Jennische E; Odén A; Holm G; Hellström M; Lönn L; Olivecrona G; Stener-Victorin E; Lönn M
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E304-11. PubMed ID: 21084397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.